These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 37529383)

  • 1. Novel transcriptomic signatures associated with premature kidney allograft failure.
    Hruba P; Klema J; Le AV; Girmanova E; Mrazova P; Massart A; Maixnerova D; Voska L; Piredda GB; Biancone L; Puga AR; Seyahi N; Sever MS; Weekers L; Muhfeld A; Budde K; Watschinger B; Miglinas M; Zahradka I; Abramowicz M; Abramowicz D; Viklicky O
    EBioMedicine; 2023 Oct; 96():104782. PubMed ID: 37660534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modest Improvements in Refractory Antibody-Mediated Rejection After Prolonged Treatment.
    Degner KR; Parajuli S; Aziz F; Garg N; Mohamed M; Mandelbrot DA; Panzer SE; Wilson NA; Reese SR; Van Hyfte K; Zhong W; Hidalgo LG; Nickerson P; Djamali A
    Kidney Int Rep; 2021 May; 6(5):1397-1401. PubMed ID: 34013117
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous surveillance for kidney transplant rejection: ready for clinical trials?
    Reindl-Schwaighofer R; Heinzel A; Oberbauer R
    Clin Kidney J; 2024 Mar; 17(3):sfad242. PubMed ID: 38495221
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder.
    Santoro JD; Spinazzi NA; Filipink RA; Hayati-Rezvan P; Kammeyer R; Patel L; Sannar EA; Dwyer L; Banerjee AK; Khoshnood M; Jafarpour S; Boyd NK; Partridge R; Gombolay GY; Christy AL; Real de Asua D; Del Carmen Ortega M; Manning MA; Van Mater H; Worley G; Franklin C; Stanley MA; Brown R; Capone GT; Quinn EA; Rafii MS
    Transl Psychiatry; 2023 Aug; 13(1):276. PubMed ID: 37553347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed?
    Habibabady Z; McGrath G; Kinoshita K; Maenaka A; Ikechukwu I; Elias GF; Zaletel T; Rosales I; Hara H; Pierson RN; Cooper DKC
    Xenotransplantation; 2023; 30(4):e12816. PubMed ID: 37548030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression.
    Wiebe C; Balshaw R; Gibson IW; Ho J; Shaw J; Karpinski M; Trachtenberg A; Pochinco D; Goldberg A; Birk P; Pinsk M; Rush DN; Nickerson PW
    Am J Transplant; 2023 Dec; 23(12):1882-1892. PubMed ID: 37543094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report.
    Nakanuma S; Gabata R; Okazaki M; Seki A; Hosokawa K; Yokoyama T; Katano K; Sugita H; Tokoro T; Takada S; Makino I; Taniguchi T; Harada K; Yagi S
    Transplant Proc; 2023 Oct; 55(8):1946-1950. PubMed ID: 37537076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients.
    Shim YE; Ko Y; Lee JP; Jeon JS; Jun H; Yang J; Kim MS; Lim SJ; Kwon HE; Jung JH; Kwon H; Kim YH; Lee J; Shin S;
    Sci Rep; 2023 Aug; 13(1):12560. PubMed ID: 37532735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multisystemic inflammatory syndrome in children after severe acute respiratory syndrome coronavirus 2 infection: a clinical analysis of four cases].
    Wang F; Liu L; Xue Y; Dan S; An XJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):685-688. PubMed ID: 37529949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange in the management of stiff person syndrome spectrum disorders: a case series and review of the literature.
    Mercure-Corriveau N; Roy S; Hu C; Crowe EP; Zhu X; Obando D; Patel EU; Tobian AAR; Wang Y; Bloch EM; Newsome SD
    Ther Adv Neurol Disord; 2023; 16():17562864231180736. PubMed ID: 37529719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients-a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN).
    Fichtner A; Gauché L; Süsal C; Tran TH; Waldherr R; Krupka K; Guzzo I; Carraro A; Oh J; Zirngibl M; Weitz M; König J; Büscher A; Berta L; Simon T; Awan A; Rusai K; Topaloglu R; Peruzzi L; Printza N; Kim JJ; Weber LT; Melk A; Pape L; Rieger S; Patry C; Höcker B; Tönshoff B;
    Pediatr Nephrol; 2024 Sep; ():. PubMed ID: 39283519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New treatment for antibody-mediated rejection: interleukin-6 inhibitors.
    Park BH; Kim YN; Shin HS
    Clin Transplant Res; 2024 Mar; 38(1):1-6. PubMed ID: 38725179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid organ transplantation and gut microbiota: a review of the potential immunomodulatory properties of short-chain fatty acids in graft maintenance.
    Jardou M; Brossier C; Marquet P; Picard N; Druilhe A; Lawson R
    Front Cell Infect Microbiol; 2024; 14():1342354. PubMed ID: 38476165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab-A Preliminary Study.
    Arrivé C; Jacquet M; Gautier-Veyret E; Jouve T; Noble J; Lombardo D; Rostaing L; Stanke-Labesque F
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-Transplant Surveillance and Management of Chronic Active Antibody-Mediated Rejection in Renal Transplant Patients in Europe.
    Rostaing LPE; Böhmig GA; Gibbons B; Taqi MM
    Transpl Int; 2023; 36():11381. PubMed ID: 37529383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience.
    Yilmaz VT; Dandin O; Kisaoglu A; Avanaz A; Kamaci D; Toru HS; Demiryilmaz I; Koksoy S; Aydinli B; Kocak H
    Transplant Proc; 2022 Sep; 54(7):1809-1815. PubMed ID: 35907695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection.
    Park WY; Kim Y; Paek JH; Jin K; Han S
    Korean J Transplant; 2021 Mar; 35(1):33-40. PubMed ID: 35769616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection.
    Remport A; Ivanyi B; Mathe Z; Tinckam K; Mucsi I; Molnar MZ
    Nephrol Dial Transplant; 2015 Nov; 30(11):1825-33. PubMed ID: 25473123
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.